Literature DB >> 24132385

Chemical and biological weapons in the 'new wars'.

Kai Ilchmann1, James Revill.   

Abstract

The strategic use of disease and poison in warfare has been subject to a longstanding and cross-cultural taboo that condemns the hostile exploitation of poisons and disease as the act of a pariah. In short, biological and chemical weapons are simply not fair game. The normative opprobrium is, however, not fixed, but context dependent and, as a social phenomenon, remains subject to erosion by social (or more specifically, antisocial) actors. The cross cultural understanding that fighting with poisons and disease is reprehensible, that they are taboo, is codified through a web of interconnected measures, principal amongst these are the 1925 Geneva Protocol; the Biological Weapons Convention; and the Chemical Weapons Convention. Whilst these treaties have weathered the storm of international events reasonably well, their continued health is premised on their being 'tended to' in the face of contextual changes, particularly facing changes in science and technology, as well as the changed nature and character of conflict. This article looks at the potential for normative erosion of the norm against chemical and biological weapons in the face of these contextual changes and the creeping legitimization of chemical and biological weapons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24132385     DOI: 10.1007/s11948-013-9479-7

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  3 in total

1.  Public health response to biological and chemical weapons: WHO guidance.

Authors: 
Journal:  Biosecur Bioterror       Date:  2005

2.  The development of the norm against the use of poison: what literature tells us.

Authors:  John Ellis van Courtland Moon
Journal:  Politics Life Sci       Date:  2008-03

3.  Resolution of the Korean War biological warfare allegations.

Authors:  M Leitenberg
Journal:  Crit Rev Microbiol       Date:  1998       Impact factor: 7.624

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.